Parma, Italy

Enrico Zambelli

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Enrico Zambelli: Innovator in Respiratory Treatments

Introduction

Enrico Zambelli is a prominent inventor based in Parma, Italy. He has made significant contributions to the field of respiratory medicine, particularly in the development of aerosol formulations for chronic obstructive pulmonary disease (COPD). With a total of 10 patents to his name, Zambelli's work has had a substantial impact on patient care.

Latest Patents

Zambelli's latest patents include innovative aerosol formulations that utilize glycopyrronium bromide. These stable aerosol solution formulations are designed for effective administration to patients suffering from COPD and other respiratory conditions. His research focuses on improving the quality of life for individuals with these challenging health issues.

Career Highlights

Throughout his career, Zambelli has been associated with Chiesi Farmaceutici S.p.a., a leading pharmaceutical company known for its commitment to respiratory health. His work at Chiesi has allowed him to collaborate with other experts in the field and contribute to groundbreaking advancements in aerosol therapy.

Collaborations

Zambelli has worked alongside talented colleagues such as Sauro Bonelli and Francesca Usberti. Their combined expertise has fostered a collaborative environment that encourages innovation and the development of effective treatment options for respiratory diseases.

Conclusion

Enrico Zambelli's contributions to aerosol formulations for COPD exemplify his dedication to improving respiratory health. His innovative patents and collaborations with esteemed colleagues highlight his role as a key figure in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…